Combination of a PD-1 antagonist and a 4-1BB agonist for the treatment of cancer

• 收藏
• 分享

专利权人:

Pfizer Inc.;Merck Sharp & Dohme Corp.

发明人:

DAVIS, Craig,KOEHLER, Maria,YAN, Li

申请号：

ES15703438

公开号：

ES2783026T3

申请日:

2015.02.03

申请国别(地区):

ES

年份:

2020

代理人:

摘要：

The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a selective 4-1BB agonist, and the use of the combination therapies for the treatment of cancer, and in particular for treating cancers that express PD-L1.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/